TERN vs TMO · $6.12B cap vs P/E 24, rev $44.56B
Terns Pharmaceuticals Inc (TERN) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
TERN currently screens at market cap $6.12B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the TERN and TMO stock pages for the full models.
Not investment advice.